BlackRock Health Sciences Term Trust (NYSE: BMEZ) AI-Powered Stock Analysis
See how BlackRock Health Sciences Term Trust scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
BMEZ●NYSE
Financial ServicesAsset Management
$17.01
$0.18(1.07%)
U.S. Market opens in 7h 29m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerBlackRock Health Sciences Term Trust (NYSE: BMEZ) Stock Overall Grade
BlackRock Health Sciences Term Trust's grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to BlackRock Health Sciences Term Trust's overall NYSE stock rating.
Forecast
BScore
65/100Financial Growth
CScore
40/100Fundamental Growth
CScore
48/100Key Ratios
B+Score
77/100Sector Comparison
AScore
80/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100BlackRock Health Sciences Term Trust (NYSE: BMEZ) AI-Powered Stock Analysis
On the NYSE, BMEZ demonstrates Good performance with an overall Forecast Score of 65/100 (B), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (48/100, C) highlight its stability, while Key Ratios (77/100, B+) and Sector Comparison (80/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NYSE: BMEZ) Component Analysis Explained
Understand the key factors behind each BlackRock Health Sciences Term Trust (NYSE: BMEZ) stock grade, including financials, comparisons, and forecasts.